IP Library › Granted Patent US 10,940,183
Granted Patent B2
US 10,940,183 · App. 16/422,704 · Granted Mar 9, 2021

Albumin-based non-covalent complexes and methods of use thereof

Inventors: Ravi Verma (Monrovia, CA); Changjun Yu (Pasadena, CA)
Assignee: Spectral Platforms, Inc.
A61K38/385A01N43/90A61K9/00C12Q1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,940,183
App. No.
16/422,704
Granted
Mar 9, 2021
Kind
B2
Abstract

A non-covalent complex of an albumin molecule and a hydrophobic ligand, compositions containing the same, and methods of use thereof are provided. The present complex may find use in delivering the hydrophobic ligand to microorganisms that have albumin-binding outer surfaces, such as a cell wall.

Claims (26)

1. A method for determining a minimum inhibitory concentration (MIC) of an antimicrobial for a microorganism, the method comprising:

a) contacting a plurality of compositions with the antimicrobial, wherein each composition of the plurality of compositions comprises a microorganism comprising a cell wall and wherein each composition is contacted with a different amount of the antimicrobial

b) contacting each composition formed in step a) with an aqueous solution comprising a non-covalent complex of a hydrophobic molecule and a single albumin protein, wherein the hydrophobic molecule functionally associates with the microorganism;

c) detecting one or more properties of the hydrophobic molecule in each composition formed in step b); and

d) determining the minimum inhibitory concentration of the antimicrobial for the microorganism based on the detecting.

2. The method of claim 1 , wherein the microorganism is a pathogenic microorganism.

3. The method of claim 1 , wherein the hydrophobic molecule is a carotenoid.

4. The method of claim 3 , wherein the carotenoid is a carotene.

5. The method of claim 4 , wherein the carotene is lycopene or β-carotene.

6. The method of claim 1 , wherein the antimicrobial is an antibacterial.

7. The method of claim 1 , wherein the antimicrobial is an antifungal.

8. The method of claim 1 , wherein the albumin protein is a human serum albumin protein.

9. The method of claim 1 , wherein the method further comprises forming the aqueous solution comprising the non-covalent complex of hydrophobic molecule and single albumin protein by:

dissolving the hydrophobic molecule in:

i) a first organic solvent comprising a C 3 -C 5 ketone; or

ii) a combination of the first organic solvent and a second organic solvent in a ratio of from about 0.001:1 to about 1000:1 v/v,

to provide a first solution;

combining the first solution with a second solution to provide a third solution, wherein the second solution is an aqueous solution comprising an albumin protein; and

removing the first organic solvent or the combination of the first organic solvent and the second organic solvent from the third solution to provide a fourth solution, wherein the fourth solution is an aqueous solution comprising a non-covalent complex of the hydrophobic molecule and a single albumin protein.

10. The method of claim 9 , wherein the C 3 -C 5 ketone is acetone.

11. The method of claim 9 , wherein the hydrophobic molecule is dissolved in the combination of a first organic solvent and a second organic solvent, and wherein the ratio of the first organic solvent and the second organic solvent is in the range of about 1:1 to about 5:1.

12. The method of claim 11 , wherein the hydrophobic molecule is dissolved in the combination, and wherein the combination comprises the first organic solvent and the second organic solvent in a ratio of about 2:1.

13. The method of claim 9 , wherein the hydrophobic molecule is dissolved in the combination, and wherein the method comprises:

dissolving the hydrophobic molecule in the second organic solvent, to provide a fifth solution; and

combining the fifth solution with the C 3 -C 5 ketone to provide the first solution prior to combining the first solution with the second solution.

14. The method of claim 9 , wherein the removing is performed by evaporation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: VERMA, RAVI; YU, CHANGJUN
To: SPECTRAL PLATFORMS INC.
Reel/Frame 050067/0832 →
Continuity (5)
Division 16056366 · Aug 6, 2018
Division 15148587 · May 6, 2016
Provisional Application 62158670 · May 8, 2015
Provisional Application 62294931 · Feb 12, 2016
Related Publication 20200121763A1 · Apr 23, 2020
Cited By (1)
US 12,357,679